23 results
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
22 Mar 24
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
8:52am
in the Journal for ImmunoTherapy of Cancer (JITC), the peer-reviewed, online journal of the Society of Immunotherapy of Cancer. The paper, entitled
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
18 Mar 24
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
4:05pm
certification as a hypertension specialist by the American Society of Hypertension.
About Checkpoint Therapeutics
Checkpoint Therapeutics, Inc. is a clinical
8-K
EX-99.1
CKPT
Checkpoint Therapeutics Inc
13 Nov 23
Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
5:10pm
of Cancer (JITC), the peer-reviewed, online journal of the Society of Immunotherapy of Cancer. The paper, entitled, “Efficacy and Safety of Cosibelimab
8-K
EX-99.1
pnk57wy
31 Mar 23
Checkpoint Therapeutics Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
6:00am
8-K
EX-99.1
o52kqwb5
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
EX-99.1
v0gzv1 6n6
12 May 22
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:45pm
8-K
EX-99.1
slaps
9 Mar 21
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights
5:17pm
8-K
EX-99.1
gis2eje7m r3ua
4 Nov 20
Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-99.1
ypgkh3
17 Sep 20
Other Events
6:39am
8-K
EX-99.1
u7ureb
5 Aug 20
Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-99.1
zv35egu474mkg ayb0
11 Mar 20
Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
4:26pm
424B5
5bqbe7
21 Nov 19
Prospectus supplement for primary offering
8:31am